Who we are

InnovaMark Technologies provides expert consulting services to pharmaceutical and biotech companies, as well as technology providers, seeking to maximize the use of advanced spatial biology platforms for innovative drug discovery. We specialize in guiding clients through the complex landscape of options, providing tailored solutions that overcome technical barriers and create clear paths for adoption. Our approach facilitates a seamless transition from early target exploration to biomarker discovery. With a focus on precision medicine, we can help bridge the gap between research and clinical development to enhance clinical trial efficiency and improve patient outcomes.

Microscopic image of breast cancer tissue with multiplexed immunofluorescence staining, showing intricate spatial patterns of cells and structures in various colors.
Microscopic image of counterstained colon cancer tissue (left), with tissue subtypes identified using digital image analysis (right).
Multiplex Immunofluorescence images depicting various cell types in a patient biospecimen (upper), including a counterstained tissue overlay showing underlying morphology (lower).

Why work with us?

  1. Extensive Expertise: Decades of experience in oncology drug discovery, translational medicine, and biomarker development across academic, pharmaceutical, and clinical settings.

  2. Innovative Solutions: Proven track record of implementing cutting-edge technologies to meet strategic needs and demonstrate return on investment. Specialization in histology, immunohistochemistry (IHC), multiplexed immunofluorescence (mIF), digital pathology, spatial transcriptomics, spatial proteomics, and multi-omics to advance cutting-edge research.

  3. Collaborative Approach: Experienced cross-functional team member driving integration into existing workflows to enhance laboratory operations, translational research, and biomarker discovery.

  4. Data-Driven Strategies: Expertise in tailoring multi-omics data integration and AI-powered image analysis to ensure that complex biological data is transformed into clear, actionable insights that drive decision-making.

  5. Industry-Leading Network: Long-standing relationships with top contract research organizations (CROs), reagent suppliers, and equipment manufacturers. Connecting clients with reliable service providers that deliver high-quality results. Strategic advisory board member for technology companies.

  6. Best Practices: Direct experience implementing good laboratory practice (GLP) for nonclinical labs to ensure quality data, building CLIA-certified and CAP-accredited labs for clinical testing, and developing laboratory developed tests (LDTs) to inform patient therapy selection.